SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection | Zendy

Chiranjib Chakraborty | Zendy; Manojit Bhattacharya | Zendy; Ashish Ranjan Sharma | Zendy; SangSoo Lee | Zendy; Govindasamy Agoramoorthy | Zendy

Open Access

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection

Author(s) -

Chiranjib Chakraborty,

Manojit Bhattacharya,

Ashish Ranjan Sharma,

SangSoo Lee,

Govindasamy Agoramoorthy

Publication year - 2021

Publication title -

annals of medicine and surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.391

H-Index - 23

ISSN - 2049-0801

DOI - 10.1016/j.amsu.2021.102428

Subject(s) - lineage (genetic) , latin americans , pandemic , public health , covid-19 , virology , medicine , biology , genetics , gene , political science , disease , infectious disease (medical specialty) , nursing , pathology , law

COVID-19 has not only created a pandemic but also affected both economically and socially in all countries. It has further created a socio-economic chaos throughout Latin America. Currently, some new SARS-CoV-2 variants are circulating in Latin America and one among the significant variant belongs to the P.1 lineage (B.1.1.28.1) that has 17 mutations. The essential modifications located in the spike glycoprotein RBD include E484K, K417T and N501Y. Along with the P.1 lineage, P.2 lineage (B.1.1.28.2) has also appeared recently. Details on all the variants are unknown, along with the Brazil variant at this time. Therefore, we call for intensive research to collect more data to understand the variants' virulence and the effects on vaccine efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research